The landscape of antibody binding affinity in SARS-CoV-2 Omicron BA.1 evolution
The Omicron BA.1 variant of SARS-CoV-2 escapes convalescent sera and monoclonal antibodies that are effective against earlier strains of the virus. This immune evasion is largely a consequence of mutations in the BA.1 receptor binding domain (RBD), the major antigenic target of SARS-CoV-2. Previous...
Main Authors: | Alief Moulana, Thomas Dupic, Angela M Phillips, Jeffrey Chang, Anne A Roffler, Allison J Greaney, Tyler N Starr, Jesse D Bloom, Michael M Desai |
---|---|
Format: | Article |
Language: | English |
Published: |
eLife Sciences Publications Ltd
2023-02-01
|
Series: | eLife |
Subjects: | |
Online Access: | https://elifesciences.org/articles/83442 |
Similar Items
-
Compensatory epistasis maintains ACE2 affinity in SARS-CoV-2 Omicron BA.1
by: Alief Moulana, et al.
Published: (2022-11-01) -
SARS‐CoV‐2 Omicron variant: Immune escape and vaccine development
by: Danyi Ao, et al.
Published: (2022-03-01) -
Insight into SARS-CoV-2 Omicron variant immune escape possibility and variant independent potential therapeutic opportunities
by: Mohammad Shah Alam
Published: (2023-02-01) -
Drastic decline in sera neutralization against SARS-CoV-2 Omicron variant in Wuhan COVID-19 convalescents
by: Chengbao Ma, et al.
Published: (2022-12-01) -
Virological Characteristics of the Omicron Variant: Key Mutations, Pathogenicity, and Immune Escape
by: CHEN Yuqing, et al.
Published: (2023-09-01)